ClinicalTrials.gov
public full text
Public Domain
Clinical Efficacy of Atomoxetine for Methamphetamine Dependence
The purpose of this study is to examine the ability of atomoxetine compared to placebo to increase time to relapse in methamphetamine dependent volunteers. Our hypothesis is that atomoxetine will increase time before (if) the participant relapses.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users#1113506
- Galantamine and CBT4CBT Pilot to Prevent Relapse.#902658
- Pilot TMS for Methamphetamine Use Disorder#883222
- A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.#850787
- Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients#981413
Record · ID 1195232
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive